Send us a text

In this special Tech Tuesday episode of The Incubator Podcast, Ben and Daphna sit down with Anthony Wu, CEO of Capnia, Inc., to explore how end-tidal carbon monoxide (ETCO) monitoring is impacting neonatal jaundice management. Anthony explains how this technology, based on decades of research, provides a real-time, non-invasive biomarker for hemolysis and thus indirectly, bilirubin production, allowing clinicians to better assess and predict neonatal jaundice severity. Unlike traditional serum bilirubin tests, which only measure bilirubin levels at a given time, ETCO screening gives insight into hemolysis rates, helping identify newborns at risk for severe jaundice before complications arise.

Anthony shares his personal motivation behind this innovation, discussing how his own children experienced neonatal jaundice and how many families suffer the emotional and financial burden of this pathology. He envisions a future where universal ETCO screening becomes standard practice, allowing for earlier interventions and reducing the risk of preventable neurological damage.

Tune in for an eye-opening discussion on how this innovation could change the way we approach neonatal jaundice forever!

As always, feel free to send us questions, comments, or suggestions to our email: [email protected]. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.

Enjoy!